Global Health [MEDANTA] vs Krishna Institute of [KIMS] Detailed Stock Comparison

Global Health
NSE
Loading...

Krishna Institute of
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Global Health wins in 15 metrics, Krishna Institute of wins in 4 metrics, with 0 ties. Global Health appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Global Health | Krishna Institute of | Better |
---|---|---|---|
P/E Ratio (TTM) | 70.43 | 79.26 | Global Health |
Price-to-Book Ratio | 11.12 | 13.97 | Global Health |
Debt-to-Equity Ratio | 21.19 | 105.70 | Global Health |
PEG Ratio | 1.42 | -8.41 | Krishna Institute of |
EV/EBITDA | 40.00 | 41.12 | Global Health |
Profit Margin (TTM) | 13.83% | 11.70% | Global Health |
Operating Margin (TTM) | 17.64% | 15.97% | Global Health |
EBITDA Margin (TTM) | 17.64% | 15.97% | Global Health |
Return on Equity | 14.21% | 15.90% | Krishna Institute of |
Return on Assets (TTM) | 10.10% | 6.70% | Global Health |
Free Cash Flow (TTM) | $-241.56M | $-4.27B | Global Health |
Dividend Yield | 0.04% | N/A | N/A |
1-Year Return | 21.09% | 43.01% | Krishna Institute of |
Price-to-Sales Ratio (TTM) | 9.74 | 9.26 | Krishna Institute of |
Enterprise Value | $372.00B | $326.44B | Global Health |
EV/Revenue Ratio | 9.63 | 10.14 | Global Health |
Gross Profit Margin (TTM) | 76.81% | 61.56% | Global Health |
Revenue per Share (TTM) | $144 | $80 | Global Health |
Earnings per Share (Diluted) | $19.88 | $9.40 | Global Health |
Beta (Stock Volatility) | -0.32 | -0.11 | Global Health |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Global Health vs Krishna Institute of Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Global Health | -1.85% | -0.77% | 3.20% | 14.78% | 19.51% | 24.83% |
Krishna Institute of | -1.83% | -1.75% | -3.46% | 11.52% | 38.93% | 19.98% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Global Health | 21.09% | 231.76% | 231.76% | 231.76% | 231.76% | 231.76% |
Krishna Institute of | 43.01% | 186.66% | 255.46% | 255.46% | 255.46% | 255.46% |
Performance & Financial Health Analysis: Global Health vs Krishna Institute of
Metric | MEDANTA | KIMS |
---|---|---|
Market Information | ||
Market Cap | ₹376.24B | ₹298.10B |
Market Cap Category | Large cap | Large cap |
10 Day Avg. Volume | 329,855 | 312,634 |
90 Day Avg. Volume | 423,799 | 571,779 |
Last Close | ₹1,374.00 | ₹723.90 |
52 Week Range | ₹935.50 - ₹1,456.50 | ₹474.05 - ₹798.40 |
% from 52W High | -5.66% | -9.33% |
All-Time High | ₹1,513.90 (Feb 12, 2024) | ₹798.40 (Jul 24, 2025) |
% from All-Time High | -9.24% | -9.33% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.20% | 0.27% |
Quarterly Earnings Growth | 0.50% | -0.09% |
Financial Health | ||
Profit Margin (TTM) | 0.14% | 0.12% |
Operating Margin (TTM) | 0.18% | 0.16% |
Return on Equity (TTM) | 0.14% | 0.16% |
Debt to Equity (MRQ) | 21.19 | 105.70 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹125.91 | ₹53.34 |
Cash per Share (MRQ) | ₹41.79 | ₹2.54 |
Operating Cash Flow (TTM) | ₹5.45B | ₹4.98B |
Levered Free Cash Flow (TTM) | ₹4.81B | ₹3.85B |
Dividends | ||
Last 12-Month Dividend Yield | 0.04% | N/A |
Last 12-Month Dividend | ₹0.50 | N/A |
Valuation & Enterprise Metrics Analysis: Global Health vs Krishna Institute of
Metric | MEDANTA | KIMS |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 70.43 | 79.26 |
Forward P/E | 59.81 | 66.70 |
PEG Ratio | 1.42 | -8.41 |
Price to Sales (TTM) | 9.74 | 9.26 |
Price to Book (MRQ) | 11.12 | 13.97 |
Market Capitalization | ||
Market Capitalization | ₹376.24B | ₹298.10B |
Enterprise Value | ₹372.00B | ₹326.44B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 9.63 | 10.14 |
Enterprise to EBITDA | 40.00 | 41.12 |
Risk & Other Metrics | ||
Beta | -0.32 | -0.11 |
Book Value per Share (MRQ) | ₹125.91 | ₹53.34 |
Financial Statements Comparison: Global Health vs Krishna Institute of
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | MEDANTA | KIMS |
---|---|---|
Revenue/Sales | ₹10.31B | ₹7.97B |
Cost of Goods Sold | ₹2.39B | ₹6.67B |
Gross Profit | ₹7.92B | ₹1.31B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹1.82B | ₹1.46B |
EBITDA | ₹2.47B | ₹2.14B |
Pre-Tax Income | ₹2.08B | ₹1.34B |
Income Tax | ₹491.59M | ₹280.00M |
Net Income (Profit) | ₹1.59B | ₹1.06B |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | MEDANTA | KIMS |
---|---|---|
Cash & Equivalents | ₹2.30B | ₹560.00M |
Total Current Assets | ₹15.33B | ₹6.97B |
Total Current Liabilities | ₹6.19B | ₹8.36B |
Long-Term Debt | ₹6.24B | ₹22.87B |
Total Shareholders Equity | ₹33.88B | ₹24.19B |
Retained Earnings | N/A | N/A |
Property, Plant & Equipment | ₹25.08B | ₹29.42B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | MEDANTA | KIMS |
---|---|---|
Operating Cash Flow | ₹1.40B | N/A |
Capital Expenditures | ₹-661.90M | N/A |
Free Cash Flow | ₹828.74M | N/A |
Debt Repayment | ₹71.87M | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | MEDANTA | KIMS |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 329,855 | 312,634 |
Average Daily Volume (90 Day) | 423,799 | 571,779 |
Shares Outstanding | 268.59M | 400.14M |
Float Shares | 87.13M | 232.42M |
% Held by Insiders | 0.68% | 0.44% |
% Held by Institutions | 0.21% | 0.40% |
Dividend Analysis & Yield Comparison: Global Health vs Krishna Institute of
Metric | MEDANTA | KIMS |
---|---|---|
Last 12-Month Dividend | ₹0.50 | N/A |
Last 12-Month Dividend Yield | 0.04% | N/A |
3-Year Avg Annual Dividend | ₹0.17 | N/A |
3-Year Avg Dividend Yield | 0.04% | N/A |
3-Year Total Dividends | ₹0.50 | N/A |
Ex-Dividend Date | Aug 22, 2025 | N/A |